山口研成 (Kensei Yamaguchi) - マイポータル

基本情報

所属: がん研究会有明病院消化器化学療法科部長

J-GLOBAL ID: 201801018833005639
researchmap会員ID: B000307223

消化器化学療法科専門消化器化学療法
臨床研究開発センター長

論文

103

Regorafenib-Induced Hand-Foot Skin Reaction Is More Severe on the Feet Than on the Hands.

Yuma Nonomiya, Takashi Yokokawa, Kazuyoshi Kawakami, Kazuo Kobayashi, Takeshi Aoyama, Tomomi Takiguchi, Takahito Sugisaki, Kenichi Suzuki, Mitsukuni Suenaga, Takeru Wakatsuki …

Oncology research 27(5) 551-556 2019年5月7日査読有り
Relationship Between Thymidine Kinase 1 Expression and Trifluridine/Tipiracil Therapy in Refractory Metastatic Colorectal Cancer: A Pooled Analysis of 2 Randomized Clinical Trials.

Takayuki Yoshino, Kentaro Yamazaki, Eiji Shinozaki, Yoshito Komatsu, Tomohiro Nishina, Hideo Baba, Akihito Tsuji, Yasushi Tsuji, Kensei Yamaguchi, Naotoshi Sugimoto …

Clinical colorectal cancer 17(4) e719-e732 2018年12月査読有り
A phase II trial of capecitabine plus cisplatin (XP) for patients with advanced gastric cancer with early relapse after S-1 adjuvant therapy: XParTS-I trial.

Kazuhiro Nishikawa, Akira Tsuburaya, Takaki Yoshikawa, Masazumi Takahashi, Kazuaki Tanabe, Kensei Yamaguchi, Shigefumi Yoshino, Tsutomu Namikawa, Toru Aoyama, Yasushi Rino …

Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association 21(5) 811-818 2018年9月査読有り
A prospective Phase II study to examine the relationship between quality of life and adverse events of first-line chemotherapy plus cetuximab in patients with KRAS wild-type unresectable metastatic colorectal cancer: QUACK trial.

Iwamoto S, Ooki A, Morita S, Hara H, Tanioka H, Satake H, Kataoka M, Kotaka M, Kagawa Y, Nakamura M …

Cancer medicine 7(9) 4217-4227 2018年9月査読有り
A randomised phase II trial of capecitabine plus cisplatin versus S-1 plus cisplatin as a first-line treatment for advanced gastric cancer: Capecitabine plus cisplatin ascertainment versus S-1 plus cisplatin randomised PII trial (XParTS II).

Nishikawa K, Tsuburaya A, Yoshikawa T, Kobayashi M, Kawada J, Fukushima R, Matsui T, Tanabe K, Yamaguchi K, Yoshino S …

European journal of cancer (Oxford, England : 1990) 101 220-228 2018年9月査読有り
Phase II trial of biweekly cetuximab and irinotecan as third-line therapy for pretreated KRAS exon 2 wild-type colorectal cancer.

Osumi H, Shinozaki E, Mashima T, Wakatsuki T, Suenaga M, Ichimura T, Ogura M, Ota Y, Nakayama I, Takahari D …

Cancer science 109(8) 2567-2575 2018年8月査読有り
Correction to: Favorable long-term outcomes of one-year adjuvant S-1 monotherapy for pathological stage II or III gastric cancer treated at a high-volume center

Yosuke Kano, Manabu Ohashi, Naoki Hiki, Daisuke Takahari, Keisho Chin, Kensei Yamaguchi, Yasuo Tsuda, Yoshiaki Shoji, Itaru Yasufuku, Kojiro Eto …

Gastric Cancer 1 2018年6月13日査読有り
Early tumor shrinkage and depth of response in patients with advanced gastric cancer: a retrospective analysis of a randomized phase III study of first-line S-1 plus oxaliplatin vs. S-1 plus cisplatin

Tomohiro Nishina, Mizutomo Azuma, Kazuhiro Nishikawa, Masahiro Gotoh, Hideaki Bando, Naotoshi Sugimoto, Kenji Amagai, Keisho Chin, Yasumasa Niwa, Akihito Tsuji …

Gastric Cancer 1-9 2018年6月9日査読有り
Japanese Society of Medical Oncology Clinical Guidelines: Molecular Testing for Colorectal Cancer Treatment, Third Edition

Kentaro Yamazaki, Hiroya Taniguchi, Takayuki Yoshino, Kiwamu Akagi, Hideyuki Ishida, Hiromichi Ebi, Kaname Nakatani, Kei Muro, Yasushi Yatabe, Kensei Yamaguchi …

Cancer Science 109(6) 2074-2079 2018年6月1日査読有り
Regional differences in advanced gastric cancer: exploratory analyses of the AVAGAST placebo arm.

Akira Sawaki, Yasuhide Yamada, Kensei Yamaguchi, Tomohiro Nishina, Toshihiko Doi, Taroh Satoh, Keisho Chin, Narikazu Boku, Yasushi Omuro, Yoshito Komatsu …

Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association 21(3) 429-438 2018年5月査読有り
Favorable long-term outcomes of one-year adjuvant S-1 monotherapy for pathological stage II or III gastric cancer treated at a high-volume center

Yosuke Kano, Manabu Ohashi, Naoki Hiki, Daisuke Takahari, Keisho Chin, Kensei Yamaguchi, Yasuo Tsuda, Yoshiaki Shoji, Itaru Yasufuku, Kojiro Eto …

Gastric Cancer 1-7 2018年4月26日査読有り
Serum leucine-rich alpha-2-glycoprotein-1 with fucosylated triantennary N-glycan: A novel colorectal cancer marker

Eiji Shinozaki, Kazuhiro Tanabe, Takashi Akiyoshi, Tomohiro Tsuchida, Yuko Miyazaki, Nozomi Kojima, Masahiro Igarashi, Masashi Ueno, Mitsukuni Suenaga, Nobuyuki Mizunuma …

BMC Cancer 18(1) 406 2018年4月11日査読有り
Clinical impact of intratumoral HER2 heterogeneity on trastuzumab efficacy in patients with HER2-positive gastric cancer

Takeru Wakatsuki, Noriko Yamamoto, Takeshi Sano, Keisho Chin, Hiroshi Kawachi, Daisuke Takahari, Mariko Ogura, Takashi Ichimura, Izuma Nakayama, Hiroki Osumi …

Journal of Gastroenterology 1-10 2018年4月9日査読有り
First-line bolus 5-fluorouracil plus leucovorin for peritoneally disseminated gastric cancer with massive ascites or inadequate oral intake

Hiroki Hara, Shigenori Kadowaki, Masako Asayama, Akira Ooki, Toko Yamada, Takako Yoshii, Kensei Yamaguchi

International Journal of Clinical Oncology 23(2) 275-280 2018年4月1日査読有り
Ramucirumab for the treatment of metastatic gastric or gastroesophageal junction adenocarcinoma following disease progression on first-line platinum- or fluoropyrimidine-containing combination therapy in Japanese patients: a phase 2, open-label study

Kensei Yamaguchi, Kazumasa Fujitani, Fumio Nagashima, Yasushi Omuro, Nozomu Machida, Tomohiro Nishina, Toshiko Koue, Mika Tsujimoto, Kaijiro Maeda, Taroh Satoh

Gastric Cancer 1-9 2018年3月5日査読有り
Associations between early tumor shrinkage and depth of response and clinical outcomes in patients treated with 1st-line chemotherapy for advanced gastric cancer

Hiroki Osumi, Daisuke Takahari, Eiji Shinozaki, Keisho Chin, Mariko Ogura, Takeru Wakatsuki, Takashi Ichimura, Izuma Nakayama, Tomohiro Matsushima, Kensei Yamaguchi

Gastric Cancer 21(2) 267-275 2018年3月1日査読有り
A retrospective analysis of ramucirumab monotherapy in previously treated Japanese patients with advanced or metastatic gastric adenocarcinoma

Satoshi Murahashi, Daisuke Takahari, Takeru Wakatsuki, Naoki Fukuda, Takashi Ichimura, Mariko Ogura, Masato Ozaka, Eiji Shinozaki, Izuma Nakayama, Tomohiro Matsushima …

International Journal of Clinical Oncology 23(1) 92-97 2018年2月1日査読有り
The subgroups of the phase III RECOURSE trial of trifluridine/tipiracil (TAS-102) versus placebo with best supportive care in patients with metastatic colorectal cancer

Eric Van Cutsem, RECOURSE Study Group, Robert J. Mayer, Stéphanie Laurent, Robert Winkler, Cristina Grávalos, Manuel Benavides, Federico Longo-Munoz, Fabienne Portales, Fortunato Ciardiello …

European Journal of Cancer 90 63-72 2018年2月1日査読有り
Early hypertension is associated with better clinical outcomes in gastric cancer patients treated with ramucirumab plus paclitaxel

Naoki Fukuda, Daisuke Takahari, Takeru Wakatsuki, Hiroki Osumi, Izuma Nakayama, Tomohiro Matsushima, Takashi Ichimura, Mariko Ogura, Masato Ozaka, Mitsukuni Suenaga …

Oncotarget 9(20) 15219-15227 2018年査読有り
Retrospective comparison of S-1 plus cisplatin versus S-1 monotherapy for the treatment of advanced gastric cancer patients with positive peritoneal cytology but without gross peritoneal metastasis

Izuma Nakayama, Keisho Chin, Tomohiro Matsushima, Daisuke Takahari, Mariko Ogura, Eiji Shinozaki, Mitsukuni Suenaga, Masato Ozaka, Takeru Wakatsuki, Takashi Ichimura …

INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY 22(6) 1060-1068 2017年12月査読有り

もっとみる